Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2027-2031

Market Size (2025)

USD 7.55 Billion

CAGR (2026-2031)

14.01%

Fastest Growing Segment

Natural 

Largest Market

North America

Market Size (2031)

USD 16.58 Billion

Market Overview

The Global Nootropics Market will grow from USD 7.55 Billion in 2025 to USD 16.58 Billion by 2031 at a 14.01% CAGR. Nootropics, defined as pharmaceutical or natural substances that enhance cognitive functions such as memory, creativity, and motivation, are witnessing a surge in global demand. This market expansion is primarily supported by an aging population seeking to mitigate neurodegenerative decline and a rising demographic of professionals aiming to optimize mental performance. This intense consumer interest in brain function is translating into tangible market gains; for instance, according to the American Botanical Council, in 2024, sales of mushroom supplements specifically marketed for cognitive health increased by 114.5% in the mainstream retail channel.

However, the industry faces a significant challenge in the form of complex and divergent regulatory frameworks across international jurisdictions. Inconsistent classification of synthetic versus natural compounds creates substantial barriers to entry, complicating global distribution strategies and increasing compliance costs. These strict labeling requirements and safety standards often delay product launches, thereby impeding the ability of manufacturers to swiftly capitalize on emerging opportunities in new regions.

Key Market Drivers

The surging adoption of nootropics in the esports and competitive gaming sector is fundamentally reshaping the market, as gamers increasingly seek supplements to enhance focus, reaction time, and mental endurance. This demographic shift has moved cognitive enhancers from niche pharmaceutical applications into mainstream consumer goods, particularly through ready-to-drink energy beverages infused with nootropic ingredients like L-tyrosine and alpha-GPC. Major beverage conglomerates are aggressively capitalizing on this trend through strategic acquisitions of gamer-centric brands to secure market share. For instance, according to Keurig Dr Pepper, October 2025, in the 'Q3 2025 Results', the recent acquisition of the lifestyle energy brand GHOST contributed 7.2 percentage points to the company's overall volume/mix growth, highlighting the immense commercial impact of this category.

Simultaneously, there is a growing consumer preference for natural and plant-based formulations, driven by skepticism towards synthetic stimulants and a desire for holistic brain health solutions. This trend has revitalized interest in traditional adaptogens and medicinal mushrooms, which are being rebranded as premium cognitive aids for stress management and mental clarity. Manufacturers are responding by launching clean-label products that promise neuroprotective benefits without the adverse effects associated with conventional caffeine-heavy supplements. According to The Vitamin Shoppe, June 2025, in the 'Health and Wellness Trend Report 2025', sales of shilajit, a natural resin marketed for cognitive support, increased by 40% in the first quarter alone. This shift is reflective of broader sentiment; according to Kyowa Hakko, January 2025, in the 'Food, beverage companies embrace brain health in 2025' article, 53% of consumers have expressed specific interest in trying beverages designed to support cognitive health.

Download Free Sample Report

Key Market Challenges

The complex and divergent regulatory frameworks across international jurisdictions act as a severe constraint on the Global Nootropics Market. Manufacturers must navigate inconsistent classifications where a single compound is viewed as a compliant dietary supplement in one country yet regulated as a restricted pharmaceutical in another. This fragmentation necessitates costly reformulations and distinct regional strategies, significantly draining financial resources and extending the time required to bring products to market. Consequently, companies are frequently unable to launch unified global campaigns, which limits their geographic reach and slows the overall pace of industry expansion.

This regulatory friction is particularly damaging given the rapid increase in consumer uptake of cognitive support products. According to the Council for Responsible Nutrition, in 2024, the usage of ashwagandha, a prominent ingredient in the nootropic sector, reached 8% of supplement users, reflecting a four-fold increase over just four years. When rigid compliance standards and approval delays hinder the availability of such high-demand ingredients, manufacturers miss critical windows of opportunity. This inability to swiftly align supply with surging consumer appetite results in substantial revenue losses and hampers the broader market's development.

Key Market Trends

Companies are increasingly utilizing artificial intelligence and machine learning algorithms to analyze consumer biometric data, lifestyle inputs, and genetic profiles to formulate highly customized nootropic stacks tailored to individual cognitive goals. This technological evolution allows for the creation of dynamic supplement regimens that adapt to a user's changing physiological needs, moving beyond static, one-size-fits-all multivitamins. The demand for such tailored solutions is substantial; according to ADM, August 2025, in the 'Four Drivers Fueling the Functional Snacking Takeover' report, 59% of global consumers expressed interest in products customized to meet their specific nutritional needs.

Beyond beverages, there is a growing trend toward alternative delivery systems such as nootropic-infused gummies, chewing gums, oral strips, and functional snacks to improve palatability and compliance. Manufacturers are actively diversifying their portfolios with these formats to overcome "pill fatigue" and attract younger demographics who prefer convenient, candy-like supplements over traditional pharmaceutical capsules. This format expansion is generating significant commercial traction; according to NutraIngredients, May 2025, in the 'Gummy innovations: Protein, beauty, and kids nutrition offer room for growth' article, Sirio Pharma reported nearly USD 40 million in sales from the APAC region alone in 2024, underscoring the rapid market uptake of non-pill delivery systems.

Segmental Insights

The Natural segment is currently recognized as the fastest-growing category within the Global Nootropics Market due to a marked shift in consumer preference toward safety and holistic wellness. This expansion is primarily driven by increasing skepticism regarding synthetic ingredients and the potential side effects associated with pharmaceutical cognitive enhancers. Consequently, individuals are prioritizing plant-based extracts and herbal formulations that offer perceived health benefits without dependency risks. Furthermore, the classification of these botanical products as dietary supplements by regulatory authorities allows for broader retail availability, thereby accelerating the adoption of natural cognitive aids across diverse consumer demographics.

Regional Insights

North America leads the Global Nootropics Market, driven by a well-established health and wellness culture that prioritizes cognitive performance. The region benefits from high consumer awareness and significant demand among professionals, students, and aging demographics seeking memory and focus enhancement. This dominance is reinforced by the presence of key market players and a robust distribution infrastructure, including widespread e-commerce and retail availability. Additionally, a favorable commercial environment for dietary supplements allows for rapid product innovation and adoption, securing North America’s position as the primary revenue-generating region.

Recent Developments

  • In September 2025, the brain health brand Neuriva, a subsidiary of Reckitt, launched Neuriva Memory 3D, a supplement designed to support short-term, long-term, and working memory. The formulation incorporated two clinically tested ingredients, a Sicilian grape extract and a whole coffee cherry extract, combined with B vitamins to optimize brain health. The Senior Brand Manager at Reckitt highlighted that the product was developed to address the multi-dimensional nature of memory function, differentiating it from single-benefit supplements. This launch aimed to provide consumers with a comprehensive, science-backed tool to proactively manage their cognitive performance and maintain mental sharpness.
  • In July 2025, Aayush Wellness Limited announced the launch of Brain Fuel Capsules, a nutraceutical product aimed at enhancing cognitive function and reducing mental fatigue. The new formulation utilized a synergistic blend of herbal ingredients, including Brahmi, Ashwagandha, and Ginkgo Biloba, which are known for their memory-enhancing and stress-reducing properties. The Managing Director of Aayush Wellness Limited emphasized that the product offered a time-tested, natural solution to cognitive challenges driven by modern lifestyles. This release marked a significant expansion of the company's product portfolio, targeting the rapidly growing brain health segment in the Indian market.
  • In November 2024, Bayer Consumer Health introduced a new product, Berocca Mind, exclusively on Amazon in the United Kingdom. This supplement was formulated with Spanish sage extract, alongside B vitamins, vitamin C, and essential minerals, to support memory and mental performance. The General Manager for Northern Europe at Bayer Consumer Health stated that the product was developed to meet the specific needs of consumers facing increased mental demands. The launch underscored the company’s strategy to expand its portfolio with targeted solutions that empower individuals to adopt a prevention-first mindset regarding their cognitive well-being.
  • In February 2024, EyePromise announced the launch of BrainPromise, a new brain health supplement formulated to support cognitive performance and neural protection. The product featured a proprietary blend of essential vitamins, minerals, and specific carotenoids such as lutein and zeaxanthin, which the company identified as beneficial for mitigating oxidative stress in brain tissue. The Chairman of EyePromise explained that their research into ocular health revealed a connection between the eyes and the brain, utilizing macular pigment optical density as a key biomarker. This launch provided consumers with a scientifically grounded solution for maintaining cognitive health and verifying supplement efficacy through measurable physiological indicators.

Key Market Players

  • Onnit
  • Neurohacker Collective
  • Mind Lab Pro
  • Nootrogen
  • HVMN
  • Gaia Herbs
  • NOW Foods
  • Thorne
  • GNC Holdings
  • Natrol

By Type

By Product Type

By Distribution Channel

By Application

By Region

  • Prescription v/s Over the Counter
  • Natural v/s Synthetic
  • Online v/s Offline
  • Memory Enhancement
  • Mood & Depression
  • Attention & Focus
  • Longevity & Anti-aging
  • Sleep & Recovery
  • Anxiety
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Nootropics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Nootropics Market, By Type:
  • Prescription v/s Over the Counter
  • Nootropics Market, By Product Type:
  • Natural v/s Synthetic
  • Nootropics Market, By Distribution Channel:
  • Online v/s Offline
  • Nootropics Market, By Application:
  • Memory Enhancement
  • Mood & Depression
  • Attention & Focus
  • Longevity & Anti-aging
  • Sleep & Recovery
  • Anxiety
  • Others
  • Nootropics Market, By Region:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nootropics Market.

Available Customizations:

Global Nootropics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Nootropics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Nootropics Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Type (Prescription v/s Over the Counter)

5.2.2.  By Product Type (Natural v/s Synthetic)

5.2.3.  By Distribution Channel (Online v/s Offline)

5.2.4.  By Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-aging, Sleep & Recovery, Anxiety, Others)

5.2.5.  By Region

5.2.6.  By Company (2025)

5.3.  Market Map

6.    North America Nootropics Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Type

6.2.2.  By Product Type

6.2.3.  By Distribution Channel

6.2.4.  By Application

6.2.5.  By Country

6.3.    North America: Country Analysis

6.3.1.    United States Nootropics Market Outlook

6.3.1.1.  Market Size & Forecast

6.3.1.1.1.  By Value

6.3.1.2.  Market Share & Forecast

6.3.1.2.1.  By Type

6.3.1.2.2.  By Product Type

6.3.1.2.3.  By Distribution Channel

6.3.1.2.4.  By Application

6.3.2.    Canada Nootropics Market Outlook

6.3.2.1.  Market Size & Forecast

6.3.2.1.1.  By Value

6.3.2.2.  Market Share & Forecast

6.3.2.2.1.  By Type

6.3.2.2.2.  By Product Type

6.3.2.2.3.  By Distribution Channel

6.3.2.2.4.  By Application

6.3.3.    Mexico Nootropics Market Outlook

6.3.3.1.  Market Size & Forecast

6.3.3.1.1.  By Value

6.3.3.2.  Market Share & Forecast

6.3.3.2.1.  By Type

6.3.3.2.2.  By Product Type

6.3.3.2.3.  By Distribution Channel

6.3.3.2.4.  By Application

7.    Europe Nootropics Market Outlook

7.1.  Market Size & Forecast

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.  By Type

7.2.2.  By Product Type

7.2.3.  By Distribution Channel

7.2.4.  By Application

7.2.5.  By Country

7.3.    Europe: Country Analysis

7.3.1.    Germany Nootropics Market Outlook

7.3.1.1.  Market Size & Forecast

7.3.1.1.1.  By Value

7.3.1.2.  Market Share & Forecast

7.3.1.2.1.  By Type

7.3.1.2.2.  By Product Type

7.3.1.2.3.  By Distribution Channel

7.3.1.2.4.  By Application

7.3.2.    France Nootropics Market Outlook

7.3.2.1.  Market Size & Forecast

7.3.2.1.1.  By Value

7.3.2.2.  Market Share & Forecast

7.3.2.2.1.  By Type

7.3.2.2.2.  By Product Type

7.3.2.2.3.  By Distribution Channel

7.3.2.2.4.  By Application

7.3.3.    United Kingdom Nootropics Market Outlook

7.3.3.1.  Market Size & Forecast

7.3.3.1.1.  By Value

7.3.3.2.  Market Share & Forecast

7.3.3.2.1.  By Type

7.3.3.2.2.  By Product Type

7.3.3.2.3.  By Distribution Channel

7.3.3.2.4.  By Application

7.3.4.    Italy Nootropics Market Outlook

7.3.4.1.  Market Size & Forecast

7.3.4.1.1.  By Value

7.3.4.2.  Market Share & Forecast

7.3.4.2.1.  By Type

7.3.4.2.2.  By Product Type

7.3.4.2.3.  By Distribution Channel

7.3.4.2.4.  By Application

7.3.5.    Spain Nootropics Market Outlook

7.3.5.1.  Market Size & Forecast

7.3.5.1.1.  By Value

7.3.5.2.  Market Share & Forecast

7.3.5.2.1.  By Type

7.3.5.2.2.  By Product Type

7.3.5.2.3.  By Distribution Channel

7.3.5.2.4.  By Application

8.    Asia Pacific Nootropics Market Outlook

8.1.  Market Size & Forecast

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.  By Type

8.2.2.  By Product Type

8.2.3.  By Distribution Channel

8.2.4.  By Application

8.2.5.  By Country

8.3.    Asia Pacific: Country Analysis

8.3.1.    China Nootropics Market Outlook

8.3.1.1.  Market Size & Forecast

8.3.1.1.1.  By Value

8.3.1.2.  Market Share & Forecast

8.3.1.2.1.  By Type

8.3.1.2.2.  By Product Type

8.3.1.2.3.  By Distribution Channel

8.3.1.2.4.  By Application

8.3.2.    India Nootropics Market Outlook

8.3.2.1.  Market Size & Forecast

8.3.2.1.1.  By Value

8.3.2.2.  Market Share & Forecast

8.3.2.2.1.  By Type

8.3.2.2.2.  By Product Type

8.3.2.2.3.  By Distribution Channel

8.3.2.2.4.  By Application

8.3.3.    Japan Nootropics Market Outlook

8.3.3.1.  Market Size & Forecast

8.3.3.1.1.  By Value

8.3.3.2.  Market Share & Forecast

8.3.3.2.1.  By Type

8.3.3.2.2.  By Product Type

8.3.3.2.3.  By Distribution Channel

8.3.3.2.4.  By Application

8.3.4.    South Korea Nootropics Market Outlook

8.3.4.1.  Market Size & Forecast

8.3.4.1.1.  By Value

8.3.4.2.  Market Share & Forecast

8.3.4.2.1.  By Type

8.3.4.2.2.  By Product Type

8.3.4.2.3.  By Distribution Channel

8.3.4.2.4.  By Application

8.3.5.    Australia Nootropics Market Outlook

8.3.5.1.  Market Size & Forecast

8.3.5.1.1.  By Value

8.3.5.2.  Market Share & Forecast

8.3.5.2.1.  By Type

8.3.5.2.2.  By Product Type

8.3.5.2.3.  By Distribution Channel

8.3.5.2.4.  By Application

9.    Middle East & Africa Nootropics Market Outlook

9.1.  Market Size & Forecast

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.  By Type

9.2.2.  By Product Type

9.2.3.  By Distribution Channel

9.2.4.  By Application

9.2.5.  By Country

9.3.    Middle East & Africa: Country Analysis

9.3.1.    Saudi Arabia Nootropics Market Outlook

9.3.1.1.  Market Size & Forecast

9.3.1.1.1.  By Value

9.3.1.2.  Market Share & Forecast

9.3.1.2.1.  By Type

9.3.1.2.2.  By Product Type

9.3.1.2.3.  By Distribution Channel

9.3.1.2.4.  By Application

9.3.2.    UAE Nootropics Market Outlook

9.3.2.1.  Market Size & Forecast

9.3.2.1.1.  By Value

9.3.2.2.  Market Share & Forecast

9.3.2.2.1.  By Type

9.3.2.2.2.  By Product Type

9.3.2.2.3.  By Distribution Channel

9.3.2.2.4.  By Application

9.3.3.    South Africa Nootropics Market Outlook

9.3.3.1.  Market Size & Forecast

9.3.3.1.1.  By Value

9.3.3.2.  Market Share & Forecast

9.3.3.2.1.  By Type

9.3.3.2.2.  By Product Type

9.3.3.2.3.  By Distribution Channel

9.3.3.2.4.  By Application

10.    South America Nootropics Market Outlook

10.1.  Market Size & Forecast

10.1.1.  By Value

10.2.  Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Product Type

10.2.3.  By Distribution Channel

10.2.4.  By Application

10.2.5.  By Country

10.3.    South America: Country Analysis

10.3.1.    Brazil Nootropics Market Outlook

10.3.1.1.  Market Size & Forecast

10.3.1.1.1.  By Value

10.3.1.2.  Market Share & Forecast

10.3.1.2.1.  By Type

10.3.1.2.2.  By Product Type

10.3.1.2.3.  By Distribution Channel

10.3.1.2.4.  By Application

10.3.2.    Colombia Nootropics Market Outlook

10.3.2.1.  Market Size & Forecast

10.3.2.1.1.  By Value

10.3.2.2.  Market Share & Forecast

10.3.2.2.1.  By Type

10.3.2.2.2.  By Product Type

10.3.2.2.3.  By Distribution Channel

10.3.2.2.4.  By Application

10.3.3.    Argentina Nootropics Market Outlook

10.3.3.1.  Market Size & Forecast

10.3.3.1.1.  By Value

10.3.3.2.  Market Share & Forecast

10.3.3.2.1.  By Type

10.3.3.2.2.  By Product Type

10.3.3.2.3.  By Distribution Channel

10.3.3.2.4.  By Application

11.    Market Dynamics

11.1.  Drivers

11.2.  Challenges

12.    Market Trends & Developments

12.1.  Merger & Acquisition (If Any)

12.2.  Product Launches (If Any)

12.3.  Recent Developments

13.    Global Nootropics Market: SWOT Analysis

14.    Porter's Five Forces Analysis

14.1.  Competition in the Industry

14.2.  Potential of New Entrants

14.3.  Power of Suppliers

14.4.  Power of Customers

14.5.  Threat of Substitute Products

15.    Competitive Landscape

15.1.  Onnit

15.1.1.  Business Overview

15.1.2.  Products & Services

15.1.3.  Recent Developments

15.1.4.  Key Personnel

15.1.5.  SWOT Analysis

15.2.  Neurohacker Collective

15.3.  Mind Lab Pro

15.4.  Nootrogen

15.5.  HVMN

15.6.  Gaia Herbs

15.7.  NOW Foods

15.8.  Thorne

15.9.  GNC Holdings

15.10.  Natrol

16.    Strategic Recommendations

17.    About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Nootropics Market was estimated to be USD 7.55 Billion in 2025.

North America is the dominating region in the Global Nootropics Market.

Natural  segment is the fastest growing segment in the Global Nootropics Market.

The Global Nootropics Market is expected to grow at 14.01% between 2026 to 2031.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.